Asia Pacific Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Facial Aesthetics Market
Market Report Description
The Asia Pacific Facial Aesthetics Market would witness market growth of 15.2% CAGR during the forecast period (2022-2028).
With the use of facial symmetry, skin tightening, and anti-aging techniques, these treatments work to make the skin look more attractive. Hyaluronic acid-based gel injections known as dermal fillers add volume to the face of the patient and fill in wrinkles. Patients can also get dermal fillers in several areas of the face, such as the cheeks, jawline, eyes, and mouth, according to the individual needs of the patient. The best technique to lessen the impact of wrinkles and folds on the face is dermal facial fillers.
Typically, the procedure lasts between 20 and 40 minutes. Skin peels are a method of skin resurfacing that enhances the color, clarity, tone, and texture of the skin. It promotes the formation of new collagen and skin cells, giving the complexion a radiant appearance. The fact that peel can be applied to practically all skin types is also an advantage. Treatments for facial aesthetics are non-invasive and non-surgical, which results in quicker recovery times and a lower chance of side effects. Additionally, the patient has nearly little pain during these procedures.
The geriatric population in the region is on a spike as India and China are among the most populous countries all over the world. According to the National Library of Medicines, India, the second most populated nation in the world, has undergone a remarkable demographic transformation over the past 50 years, with the elderly population nearly tripling. This trend is most likely to continue in the coming years due to a number of factors. The percentage of Indians aged 60 and over is anticipated to increase from 7.5% to 11.1% in 2025. This increase in percentage terms is negligible, but the absolute amount is extraordinary.
The China market dominated the Asia Pacific Facial Aesthetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,264.4 million by 2028. The Japan market is estimated to grow a CAGR of 14.5% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.9% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
Scope of the Study
Market Segments Covered in the Report:
- Dermal fillers
- Botulinum toxin
- Chemical peels
- Facial line correction treatment
- Scar treatment
- Lip enhancement
- Restoration of volume or Fullness
By End User
- Specialty & Dermatology Clinics
- South Korea
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free